Beyond the Coronary Angiogram: Further Evaluation of the Coronary Vasculature and Endothelial Function

Coronary artery disease is a progressive and diffuse process. The focus in the past decade was on the late stage of coronary atherosclerosis, with efforts being devoted to the development of thrombolytic drugs and sophisticated interventional devices. However, in spite of the success in decreasing morbidity and mortality from coronary atherosclerosis, the disease process continues. Early diagnosis and treatment of patients with nonobstructive coronary artery disease, may prevent the development of unstable angina and myocardial infarction. It has become apparent that the endothelium is the primary target and/or participant in the early stages of coronary atherosclerosis. The endothelium is as an active paracrine organ capable of regulating coronary vascular tone as well as the atherosclerotic and restenosis process by releasing vasorelaxing factors with antiproliferative activity and vasoconstricting and growth factors. During the evolution of coronary atherosclerosis endothelial dysfunction occurs, which is characterized by attenuated release and activity of endothelium derived vasorelaxing factors and enhanced release of vasoconstricting factors. The goal of cardiology is to develop diagnostic methods and treatment for these patients who present to us with cardiac symptoms and nonobstructive coronary artery disease. This article will review the current knowledge of endothelial function as it applies to coronary circulation and describe a clinical approach to the patient with suspected coronary disease and a normal coronary angiogram. (J Interven Cardiol 1996;9:153–161)

[1]  M. Yanagisawa The endothelin system. A new target for therapeutic intervention. , 1994, Circulation.

[2]  S. Moncada,et al.  The L-arginine-nitric oxide pathway. , 1993, The New England journal of medicine.

[3]  V. Fuster,et al.  Circulating and Tissue Endothelin Immunoreactivit in Hypercholesterolemic Pigs , 1993, Circulation.

[4]  A M Zeiher,et al.  Endothelium-mediated coronary blood flow modulation in humans. Effects of age, atherosclerosis, hypercholesterolemia, and hypertension. , 1993, The Journal of clinical investigation.

[5]  A. Nitenberg,et al.  Acetylcholine-induced coronary vasoconstriction in young, heavy smokers with normal coronary arteriographic findings. , 1993, The American journal of medicine.

[6]  C. Lau,et al.  Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolaemic patients , 1993, The Lancet.

[7]  A. Takeshita,et al.  Evidence of impaired endothelium-dependent coronary vasodilatation in patients with angina pectoris and normal coronary angiograms. , 1993, The New England journal of medicine.

[8]  D. Harrison,et al.  The Nitrovasodilators New Ideas About Old Drugs , 1993, Circulation.

[9]  T. Lüscher,et al.  Molecular and cellular biology of endothelin and its receptors--Part I. , 1993, Journal of hypertension.

[10]  M. Sugimachi,et al.  Impaired coronary blood flow response to acetylcholine in patients with coronary risk factors and proximal atherosclerotic lesions. , 1993, The Journal of clinical investigation.

[11]  R. Rodeheffer,et al.  Increased plasma concentrations of endothelin in congestive heart failure in humans. , 1992, Mayo Clinic proceedings.

[12]  P. Poole‐Wilson,et al.  Pathogenesis of Congestive State in Chronic Obstructive Pulmonary Disease: Studies of Body Water and Sodium, Renal Function, Hemodynamics, and Plasma Hormones During Edema and After Recovery , 1992, Circulation.

[13]  B. Liang Adenosine receptors and cardiovascular function. , 1992, Trends in cardiovascular medicine.

[14]  H. M. Payne,et al.  Validation of A Doppler Guide Wire for Intravascular Measurement of Coronary Artery Flow Velocity , 1992, Circulation.

[15]  V. Fuster,et al.  The pathogenesis of coronary artery disease and the acute coronary syndromes (2). , 1992, The New England journal of medicine.

[16]  T. Fukami,et al.  Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptor. , 1992, Life sciences.

[17]  A. Yeung,et al.  The effect of atherosclerosis on the vasomotor response of coronary arteries to mental stress. , 1991, The New England journal of medicine.

[18]  M. Hori,et al.  Coronary Circulation , 2005 .

[19]  A. Lerman,et al.  Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. , 1991, The New England journal of medicine.

[20]  J. Kaski,et al.  Mechanisms of coronary artery spasm. , 1991, Trends in cardiovascular medicine.

[21]  M. Yanagisawa,et al.  Molecular and Cellular Mechanism of Endothelin Regulation: Implications for Vascular Function , 1991, Circulation.

[22]  D. Faller,et al.  Hypoxia induces endothelin gene expression and secretion in cultured human endothelium. , 1991, The Journal of clinical investigation.

[23]  S. Moncada,et al.  Effects of inhibition of nitric oxide formation on basal vasomotion and endothelium-dependent responses of the coronary arteries in awake dogs. , 1991, The Journal of clinical investigation.

[24]  A. Lerman,et al.  Endothelin Has Biological Actions at Pathophysiological Concentrations , 1991, Circulation.

[25]  G. Rubanyi Reversal of hypercholesterolemia-induced endothelial dysfunction by L-arginine. , 1991, Circulation.

[26]  M. Yanagisawa,et al.  Increased plasma level of endothelin-1 and coronary spasm induction in patients with vasospastic angina pectoris. , 1991, Circulation.

[27]  H. Drexler,et al.  Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis. , 1991, Circulation.

[28]  H. Drexler,et al.  Assessment of coronary vasomotor tone in humans. , 1991, Basic research in cardiology.

[29]  Y Dohi,et al.  Endothelium-dependent control of vascular tone: effects of age, hypertension and lipids. , 1991, Basic research in cardiology.

[30]  D. Harrison,et al.  Diet-induced atherosclerosis increases the release of nitrogen oxides from rabbit aorta. , 1990, The Journal of clinical investigation.

[31]  K. Margulies,et al.  Endothelin: a new cardiovascular regulatory peptide. , 1990, Mayo Clinic proceedings.

[32]  M. Marcus,et al.  Understanding the Coronary Circulation Through Studies at the Microvascular Level , 1990, Circulation.

[33]  J. Loscalzo,et al.  Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. , 1990, The Journal of clinical investigation.

[34]  A. Yeung,et al.  Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. , 1990, Circulation.

[35]  K. Nakao,et al.  Increased plasma endothelin level in patients with essential hypertension. , 1990, The New England journal of medicine.

[36]  E. Feigl,et al.  Acetylcholine Causes Coronary Vasodilation in Dogs and Baboons , 1989, Circulation research.

[37]  M. Clozel,et al.  Effects of Endothelin on the Coronary Vascular Bed in Open-Chest Dogs , 1989, Circulation research.

[38]  M. Yanagisawa,et al.  INCREASED PLASMA CONCENTRATIONS OF ENDOTHELIN-1 AND BIG ENDOTHELIN-1 IN ACUTE MYOCARDIAL INFARCTION , 1989, The Lancet.

[39]  P. Yock,et al.  Two-dimensional intravascular ultrasound: technical development and initial clinical experience. , 1989, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[40]  M. Yanagisawa,et al.  Endothelin-1 induces vasoconstriction through two functionally distinct pathways in porcine coronary artery: contribution of phosphoinositide turnover. , 1989, Biochemical and biophysical research communications.

[41]  E. Nabel,et al.  Atherosclerosis influences the vasomotor response of epicardial coronary arteries to exercise. , 1989, The Journal of clinical investigation.

[42]  N. Matsuki,et al.  Endothelin activates the dihydropyridine-sensitive, voltage-dependent Ca2+ channel in vascular smooth muscle. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[43]  S. Moncada,et al.  A specific inhibitor of nitric oxide formation from l‐arginine attenuates endothelium‐dependent relaxation , 1989, British journal of pharmacology.

[44]  M. Redfield,et al.  Integrated cardiac, renal, and endocrine actions of endothelin. , 1989, The Journal of clinical investigation.

[45]  H. Shimokawa,et al.  Dietary cod-liver oil improves endothelium-dependent responses in hypercholesterolemic and atherosclerotic porcine coronary arteries. , 1988, Circulation.

[46]  K. Zitnay,et al.  Loss of Selective Endothelial Cell Vasoactive Functions Caused by Hypercholesterolemia in Pig Coronary Arteries , 1988, Circulation research.

[47]  S. Moncada,et al.  Vascular endothelial cells synthesize nitric oxide from L-arginine , 1988, Nature.

[48]  Sadao Kimura,et al.  A novel potent vasoconstrictor peptide produced by vascular endothelial cells , 1988, Nature.

[49]  F. Klocke,et al.  Measurements of coronary flow reserve: defining pathophysiology versus making decisions about patient care. , 1987, Circulation.

[50]  S. Moncada,et al.  ENDOGENOUS NITRIC OXIDE INHIBITS HUMAN PLATELET ADHESION TO VASCULAR ENDOTHELIUM , 1987, The Lancet.

[51]  S. Moncada,et al.  Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor , 1987, Nature.

[52]  R. Frye,et al.  Vasoconstrictor activity of coronary sinus plasma from patients with coronary artery disease. , 1987, Journal of the American College of Cardiology.

[53]  P. Vanhoutte,et al.  Biphasic release of endothelium-derived relaxing factor(s) by acetylcholine from perfused canine femoral arteries. Characterization of muscarinic receptors. , 1987, The Journal of pharmacology and experimental therapeutics.

[54]  R. Ballard-Barbash,et al.  Marine fish oils: role in prevention of coronary artery disease. , 1987, Mayo Clinic proceedings.

[55]  P. Ganz,et al.  Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. , 1986, The New England journal of medicine.

[56]  R. Paul,et al.  Eicosonoid metabolism and beta-adrenergic mechanisms in coronary arterial smooth muscle: potential compartmentation of cAMP. , 1986, The American journal of physiology.

[57]  R. Thompson,et al.  Ligand selectivity of dog coronary adenosine receptor resembles that of adenylate cyclase stimulatory (Ra) receptors. , 1983, The Journal of pharmacology and experimental therapeutics.

[58]  R. Furchgott Role of endothelium in responses of vascular smooth muscle. , 1983, Circulation research.

[59]  F. Murad,et al.  Agonist‐Induced Endothelium‐Dependent Relaxation in Rat Thoracic Aorta May Be Mediated through cGMP , 1983, Circulation research.

[60]  M. Bertrand,et al.  Frequency of provoked coronary arterial spasm in 1089 consecutive patients undergoing coronary arteriography. , 1982, Circulation.

[61]  R. Furchgott,et al.  The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine , 1980, Nature.

[62]  C. Londos,et al.  Two distinct adenosine-sensitive sites on adenylate cyclase. , 1977, Proceedings of the National Academy of Sciences of the United States of America.